Omima M. I. Adly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Omima M. I. Adly has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Ali Taha
Department of Chemistry, Faculty of Education Ain Shams University Cairo Egypt
6 shared publications Magdy A. Ibrahim
Chemistry Department, Faculty of Education, Ain-Shams University, Roxy, Cairo, Egypt
6 shared publications- Magdy Ahmed Ibrahim
Department of Chemistry, Faculty of Education, Ain Shams University, Roxy, 11711, Cairo, Egypt
6 shared publications - Adel A. A. Emara
Department of Chemistry, Faculty of Education Ain Shams University Cairo Egypt
5 shared publications - Ebtesam M. Abdelrhman
Department of Chemistry, Faculty of Education Ain Shams University Cairo Egypt
5 shared publications - Nesma Salah
Department of Chemistry, Faculty of Education Ain Shams University Cairo Egypt
5 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (49) , 67130-67152
Electronic structure and optoelectronic performance of a nanostructured copper( ii ) pyranoquinoline complex: DFT insights for temperature-sensing and photodetection applications
Cu( ii ) complexes offer promising opportunities for advanced sensing and photodetection.
- 11 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (49) , 67130-67152
Open AccessElectronic structure and optoelectronic performance of a nanostructured copper( ii ) pyranoquinoline complex: DFT insights for temperature-sensing and photodetection applications
Cu( ii ) complexes offer promising opportunities for advanced sensing and photodetection.
- 6 September 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1381
Copper(II)-Complexes Based 2-Aminochromone-3-carboxaldehyde: Spectroscopic, DFT, Solvatochromic, and Biological Studies
- 6 September 2026
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1381
Copper(II)-Complexes Based 2-Aminochromone-3-carboxaldehyde: Spectroscopic, DFT, Solvatochromic, and Biological Studies
- Open Access
- 25 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 13406
Solvatochromic, spectroscopic, DFT calculations, antimicrobial and docking studies of new Fe(III), Co(II), and Ni(II) chelates containing 1,2,4-triazine
This study presents the synthesis and characterization of three novel metal chelates: Ni(DTHMN) ( 1 ), Co(DTHMN) ( 2 ), and Fe(DTHMN) ( 3 ). Comprehensive analytical techniques, including elemental analysis, infrared (IR) and electronic (UV-Vis) spectroscopy, thermal analysis, molar conductivity, and magnetic susceptibility measurements, were employed to investigate their structural and electronic properties. The findings indicate that the ligand DTHMN acts as a tridentate donor, coordinating through the hydroxyl group (O–H), azomethine nitrogen (C = N), and triazine nitrogen atoms, forming mononuclear chelates with tetrahedral or octahedral geometries. X-ray diffraction (XRD) and transmission electron microscopy (TEM) analyses confirmed that the Ni(DTHMN) chelate adopts a nano-spherical to cubic morphology. All synthesized chelates exhibit luminescence behavior, suggesting potential utility in photoactive materials. Solvatochromic shifts in absorption and fluorescence spectra were analyzed to estimate ground-state (µ g ) and excited-state (µ e ) dipole moments. These were determined using Reichardt’s solvent polarity parameter (E T N ) and multiple empirical functions, including the Bilot–Kawski, Lippert–Mataga, Bakhshiev, and Kawski–Chamma–Viallet models. A notable increase in dipole moment upon excitation suggests enhanced stabilization of the excited state in polar solvents, particularly involving n–π* transitions. Density Functional Theory (DFT) calculations, performed using the B3LYP/GENECP method with a 6-311G(d, p) basis set for non-metal atoms and SDD for metal atoms, supported experimental data and provided insights into optimized structural parameters. Further computational analyses included molecular electrostatic potential (MEP) mapping and nonlinear optical (NLO) property evaluation, revealing charge distribution and optical characteristics. The antimicrobial activity of the complexes was tested against a panel of Gram-positive, Gram-negative bacteria, and fungi, showing promising efficacy. Finally, molecular docking studies were conducted to investigate the binding interactions of the chelates with the FabH–CoA enzyme complex (PDB ID: 1HNJ), providing insight into their potential as bioactive agents.
- 25 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 13406
Open AccessSolvatochromic, spectroscopic, DFT calculations, antimicrobial and docking studies of new Fe(III), Co(II), and Ni(II) chelates containing 1,2,4-triazine
This study presents the synthesis and characterization of three novel metal chelates: Ni(DTHMN) ( 1 ), Co(DTHMN) ( 2 ), and Fe(DTHMN) ( 3 ). Comprehensive analytical techniques, including elemental analysis, infrared (IR) and electronic (UV-Vis) spectroscopy, thermal analysis, molar conductivity, and magnetic susceptibility measurements, were employed to investigate their structural and electronic properties. The findings indicate that the ligand DTHMN acts as a tridentate donor, coordinating through the hydroxyl group (O–H), azomethine nitrogen (C = N), and triazine nitrogen atoms, forming mononuclear chelates with tetrahedral or octahedral geometries. X-ray diffraction (XRD) and transmission electron microscopy (TEM) analyses confirmed that the Ni(DTHMN) chelate adopts a nano-spherical to cubic morphology. All synthesized chelates exhibit luminescence behavior, suggesting potential utility in photoactive materials. Solvatochromic shifts in absorption and fluorescence spectra were analyzed to estimate ground-state (µ g ) and excited-state (µ e ) dipole moments. These were determined using Reichardt’s solvent polarity parameter (E T N ) and multiple empirical functions, including the Bilot–Kawski, Lippert–Mataga, Bakhshiev, and Kawski–Chamma–Viallet models. A notable increase in dipole moment upon excitation suggests enhanced stabilization of the excited state in polar solvents, particularly involving n–π* transitions. Density Functional Theory (DFT) calculations, performed using the B3LYP/GENECP method with a 6-311G(d, p) basis set for non-metal atoms and SDD for metal atoms, supported experimental data and provided insights into optimized structural parameters. Further computational analyses included molecular electrostatic potential (MEP) mapping and nonlinear optical (NLO) property evaluation, revealing charge distribution and optical characteristics. The antimicrobial activity of the complexes was tested against a panel of Gram-positive, Gram-negative bacteria, and fungi, showing promising efficacy. Finally, molecular docking studies were conducted to investigate the binding interactions of the chelates with the FabH–CoA enzyme complex (PDB ID: 1HNJ), providing insight into their potential as bioactive agents.
- Open Access
- 29 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Design, biological evaluation, solvatochromic, DFT, and molecular docking studies of new metal complexes derived from a semicarbazone ligand
The current study describes the synthesis and characterization of novel Ni(II), Co(II), and Fe(III) complexes of the semicarbazone ligand (ACMHCA). Spectroscopic, conductance, elemental, and magnetic studies confirmed octahedral geometries. Solvatochromic fluorescence analyses, supported by DFT/TD-DFT calculations, revealed higher excited-state dipole moments indicating increased polarity upon excitation. Among the complexes, Co(II)-ACMHCA displayed the highest polarizability and hyperpolarizability, suggesting potential in optoelectronics. Biological assays demonstrated notable antimicrobial and anticancer activities, with docking studies confirming strong receptor binding. These findings highlight the therapeutic and functional potential of ACMHCA-based metal complexes.
- 29 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Open AccessDesign, biological evaluation, solvatochromic, DFT, and molecular docking studies of new metal complexes derived from a semicarbazone ligand
The current study describes the synthesis and characterization of novel Ni(II), Co(II), and Fe(III) complexes of the semicarbazone ligand (ACMHCA). Spectroscopic, conductance, elemental, and magnetic studies confirmed octahedral geometries. Solvatochromic fluorescence analyses, supported by DFT/TD-DFT calculations, revealed higher excited-state dipole moments indicating increased polarity upon excitation. Among the complexes, Co(II)-ACMHCA displayed the highest polarizability and hyperpolarizability, suggesting potential in optoelectronics. Biological assays demonstrated notable antimicrobial and anticancer activities, with docking studies confirming strong receptor binding. These findings highlight the therapeutic and functional potential of ACMHCA-based metal complexes.
- Open Access
- 30 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (28) , 22972-22988
Copper(ii) chelates of a coumarin-based acyl hydrazone ligand: structural characterization and computational evaluations for prospective applications in antimicrobial, antiviral, antioxidant, and anticancer therapies
This study represents the synthesis and comprehensive characterization of four novel copper(II) chelates (CuR, CuRCT, CuH, and CuHCT) derived from a newly developed coumarin-based acyl hydrazone ligand (HCBH). The chelates were prepared using multidisciplinary synthetic routes, including reflux and hydrothermal methods with or without surfactant assistance, resulting in distinct mono- and binuclear structures with nanoscale morphologies. Structural analyses confirmed that all copper complexes possess tetrahedral geometries, with ligand coordination modes varying between tridentate and tetradentate depending on the synthetic method. TEM imaging revealed unique morphologies for each chelate, and the successful dispersion of the bioactive CuH chelate into silica yielded a porous nanostructured drug delivery system. Biological evaluations revealed promising antimicrobial activity, particularly for CuHCT against E. coli and S. aureus, and for CuRCT against B. subtilis and C. albicans. Antioxidant assays showed that CuRCT and CuHCT exhibited superior activity compared to other complexes and standard ascorbic acid. CuH demonstrated potent cytotoxicity against HepG-2 and MCF-7 cancer cell lines, comparable to cisplatin, while maintaining moderate toxicity toward normal Vero cells (CC50 = 43.34 ± 1.98 μg ml−1). Although the antiviral activity of CuH against HAV was weak, in vitro release studies of CuH–silica composites confirmed controlled release behavior, supporting its potential as a nanodrug delivery system. Density Functional Theory (DFT) and molecular docking analyses corroborated the biological findings, with favorable interactions observed between the compounds and CDK2 kinase. Collectively, these results highlight CuH as a highly promising candidate for further preclinical evaluation, especially in cancer therapy, with silica-based dispersion enhancing its potential as a nanocarrier for targeted drug delivery.
- 30 June 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (28) , 22972-22988
Open AccessCopper(ii) chelates of a coumarin-based acyl hydrazone ligand: structural characterization and computational evaluations for prospective applications in antimicrobial, antiviral, antioxidant, and anticancer therapies
This study represents the synthesis and comprehensive characterization of four novel copper(II) chelates (CuR, CuRCT, CuH, and CuHCT) derived from a newly developed coumarin-based acyl hydrazone ligand (HCBH). The chelates were prepared using multidisciplinary synthetic routes, including reflux and hydrothermal methods with or without surfactant assistance, resulting in distinct mono- and binuclear structures with nanoscale morphologies. Structural analyses confirmed that all copper complexes possess tetrahedral geometries, with ligand coordination modes varying between tridentate and tetradentate depending on the synthetic method. TEM imaging revealed unique morphologies for each chelate, and the successful dispersion of the bioactive CuH chelate into silica yielded a porous nanostructured drug delivery system. Biological evaluations revealed promising antimicrobial activity, particularly for CuHCT against E. coli and S. aureus, and for CuRCT against B. subtilis and C. albicans. Antioxidant assays showed that CuRCT and CuHCT exhibited superior activity compared to other complexes and standard ascorbic acid. CuH demonstrated potent cytotoxicity against HepG-2 and MCF-7 cancer cell lines, comparable to cisplatin, while maintaining moderate toxicity toward normal Vero cells (CC50 = 43.34 ± 1.98 μg ml−1). Although the antiviral activity of CuH against HAV was weak, in vitro release studies of CuH–silica composites confirmed controlled release behavior, supporting its potential as a nanodrug delivery system. Density Functional Theory (DFT) and molecular docking analyses corroborated the biological findings, with favorable interactions observed between the compounds and CDK2 kinase. Collectively, these results highlight CuH as a highly promising candidate for further preclinical evaluation, especially in cancer therapy, with silica-based dispersion enhancing its potential as a nanocarrier for targeted drug delivery.
- 11 May 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (6)
New Metal Complexes Based on Chromone and Triazine Moieties as Potential Antitumor Agents: Full Structural Elucidation, Theoretical Calculations, and Biological Studies
The study focused on the synthesis, structural analysis, and characterization of four metal complexes (Ni‐MCT, Co‐MCT, VO‐MCT, and Cd‐MCT) derived from 6‐methyl‐4‐[(chromon‐3‐yl)methylidene]amino‐3‐thioxo‐3,4‐dihydro‐1,2,4‐triazin‐5(2H)‐one (MCT) as a ligand. A range of techniques including elemental analysis, UV–Vis, FT‐IR, 1H‐NMR, ESR, XRD, molar conductivity, magnetic susceptibility, and thermal analysis were used to confirm the octahedral structures. The ligand coordinated with the metal ion via O, N, and S donor atoms, forming mononuclear complexes. The anticancer potential was evaluated using HepG‐2 liver cancer cells, revealing that Cd‐MCT and VO‐MCT exhibited notable cytotoxic effects, with IC50 values lower than those of other synthesized complexes and conventional chemotherapeutic drugs. Additionally, cytotoxicity was assessed in normal human cells, where VO‐MCT demonstrated a comparatively higher IC50 value, indicating lower toxicity to healthy cells than the other compounds. DFT calculations supported the molecular structures and provided quantum chemical insights of the current complexes. A QSAR model correlated DFT‐derived descriptors with biological activity (pIC50). ADMET analysis indicated promising oral bioavailability. The molecular docking studies suggested an interaction with the CDK2 kinase, highlighting Cd‐MCT and VO‐MCT as promising candidates for further pharmacological exploration in drug development.
- 11 May 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (6)
New Metal Complexes Based on Chromone and Triazine Moieties as Potential Antitumor Agents: Full Structural Elucidation, Theoretical Calculations, and Biological Studies
The study focused on the synthesis, structural analysis, and characterization of four metal complexes (Ni‐MCT, Co‐MCT, VO‐MCT, and Cd‐MCT) derived from 6‐methyl‐4‐[(chromon‐3‐yl)methylidene]amino‐3‐thioxo‐3,4‐dihydro‐1,2,4‐triazin‐5(2H)‐one (MCT) as a ligand. A range of techniques including elemental analysis, UV–Vis, FT‐IR, 1H‐NMR, ESR, XRD, molar conductivity, magnetic susceptibility, and thermal analysis were used to confirm the octahedral structures. The ligand coordinated with the metal ion via O, N, and S donor atoms, forming mononuclear complexes. The anticancer potential was evaluated using HepG‐2 liver cancer cells, revealing that Cd‐MCT and VO‐MCT exhibited notable cytotoxic effects, with IC50 values lower than those of other synthesized complexes and conventional chemotherapeutic drugs. Additionally, cytotoxicity was assessed in normal human cells, where VO‐MCT demonstrated a comparatively higher IC50 value, indicating lower toxicity to healthy cells than the other compounds. DFT calculations supported the molecular structures and provided quantum chemical insights of the current complexes. A QSAR model correlated DFT‐derived descriptors with biological activity (pIC50). ADMET analysis indicated promising oral bioavailability. The molecular docking studies suggested an interaction with the CDK2 kinase, highlighting Cd‐MCT and VO‐MCT as promising candidates for further pharmacological exploration in drug development.
- 29 October 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (2)
Selective Metal‐Coordinated Nanodrugs Based on Thiazine Moiety for Anticancer Therapeutics: Spectroscopic, Theoretical, and Molecular Docking Studies
The current study involved production, comprehensive structural analysis, and physicochemical characterizing of two distinctive complexes namely, Cu( TBH ) and Zn( TBH ); TBH donor ligand: N′‐(1‐(3,6‐dihydro‐4‐hydroxy‐2,6‐dioxo‐2H‐1,3‐thiazin‐5‐yl)ethylidene)‐2‐hydroxybenzohydrazide) using a wide range of analytical methods, including elemental analysis, UV–Vis, FT‐IR, and 1 HNMR spectrometry, molar conductivity and magnetic susceptibility measurements, and thermal analysis. According to the findings, chelation can occur through O, N, and O donor atoms of monoanionic chelator for generating mono‐nuclear chelates with tetrahedral geometry for Cu (II) and octahedral geometry for Zn (II). The anticarcinogenic ability of TBH chelator and its coordinated compounds against human liver cancer (HepG‐2) was investigated. The Cu( TBH ) complex was found to have selective and promising anticancer activity against a liver cancer cell line, with lower IC 50 (liver carcinoma cell line) and higher IC 50 (normal human cell line) values than other produced compounds and standard drugs. Utilizing DFT computations, the molecular structures of the TBH and its complexes were verified, offering a detailed understanding of their quantum chemical characteristics. A quantitative structure–activity relationship (QSAR) model, which illustrates the association between DFT‐computed descriptors and biological activities pIC 50 , was also created using multiple linear regression (MLR) on the synthesized compounds as anticancer medicines. Additionally, there are no issues with the produced compounds' oral bioavailability according to (ROF) Lipinski's rule of five. Furthermore, docking studies of the synthesized TBH chelator and its chelates with CDK2 kinase have been performed to validate the biological findings. According to our findings, the novel Cu( TBH ) nanodrug exhibits considerable cytotoxic activity, prompting further study into its pharmacological profile and exploring its potential in drug development.
- 29 October 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (2)
Selective Metal‐Coordinated Nanodrugs Based on Thiazine Moiety for Anticancer Therapeutics: Spectroscopic, Theoretical, and Molecular Docking Studies
The current study involved production, comprehensive structural analysis, and physicochemical characterizing of two distinctive complexes namely, Cu( TBH ) and Zn( TBH ); TBH donor ligand: N′‐(1‐(3,6‐dihydro‐4‐hydroxy‐2,6‐dioxo‐2H‐1,3‐thiazin‐5‐yl)ethylidene)‐2‐hydroxybenzohydrazide) using a wide range of analytical methods, including elemental analysis, UV–Vis, FT‐IR, and 1 HNMR spectrometry, molar conductivity and magnetic susceptibility measurements, and thermal analysis. According to the findings, chelation can occur through O, N, and O donor atoms of monoanionic chelator for generating mono‐nuclear chelates with tetrahedral geometry for Cu (II) and octahedral geometry for Zn (II). The anticarcinogenic ability of TBH chelator and its coordinated compounds against human liver cancer (HepG‐2) was investigated. The Cu( TBH ) complex was found to have selective and promising anticancer activity against a liver cancer cell line, with lower IC 50 (liver carcinoma cell line) and higher IC 50 (normal human cell line) values than other produced compounds and standard drugs. Utilizing DFT computations, the molecular structures of the TBH and its complexes were verified, offering a detailed understanding of their quantum chemical characteristics. A quantitative structure–activity relationship (QSAR) model, which illustrates the association between DFT‐computed descriptors and biological activities pIC 50 , was also created using multiple linear regression (MLR) on the synthesized compounds as anticancer medicines. Additionally, there are no issues with the produced compounds' oral bioavailability according to (ROF) Lipinski's rule of five. Furthermore, docking studies of the synthesized TBH chelator and its chelates with CDK2 kinase have been performed to validate the biological findings. According to our findings, the novel Cu( TBH ) nanodrug exhibits considerable cytotoxic activity, prompting further study into its pharmacological profile and exploring its potential in drug development.
- 9 October 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (1)
New Metal Complexes Incorporating Schiff Base Ligand Based on Pyridine Moiety: Synthesis, Spectral Characterization, DFT, Biological Evaluation, and Molecular Docking
A new Schiff base ligand, HNMPC, was prepared and reacted with some metal ions, including Cu(II), Ni(II), Co(II), Mn(II), and VO(IV). The infrared, electronic, mass, electron spin resonance, nuclear magnetic resonance, thermal and elemental analysis, molar conductance, and magnetic susceptibility measurements were used to characterize the metal complexes. The HNMPC ligand acts as a monoanionic tridentate ONO donor in all complexes, and the coordinating sites are C=Opyridone, C=N, and the phenolate anion. All metal complexes exhibit octahedral configurations, and the results showed that the metal ion:ligand ratio was 1:2. The molecular structural parameters of the ligand and its metal complexes were determined based on the DFT level implemented in the Gaussian 09 program B3LYP/GENECP method at the 6‐311G(d,p) basis set for C, H, N, and O atoms and the SDD (Stuttgart/Dresden) basis set for the metal atoms. The theoretical data were correlated with the experimental results. Gram‐positive bacteria, Gram‐negative bacteria, yeast, and fungi were used to test the current compounds' antimicrobial activity. Investigating the antitumor activity of the ligand and its complexes against the HepG2 cell lines showed encouraging IC50 values that were on par with those of cisplatin. In order to determine the affinity and binding pattern for the synthesized compounds toward the VEGFR‐2 active site, molecular docking studies were conducted, and the results were correlated with antitumor data. Based on the obtained results, future work aimed to synthesize a new category of Schiff bases and their metal complexes derived from the current aminopyridine derivative with diverse aldehydes and ketones.
- 9 October 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (1)
New Metal Complexes Incorporating Schiff Base Ligand Based on Pyridine Moiety: Synthesis, Spectral Characterization, DFT, Biological Evaluation, and Molecular Docking
A new Schiff base ligand, HNMPC, was prepared and reacted with some metal ions, including Cu(II), Ni(II), Co(II), Mn(II), and VO(IV). The infrared, electronic, mass, electron spin resonance, nuclear magnetic resonance, thermal and elemental analysis, molar conductance, and magnetic susceptibility measurements were used to characterize the metal complexes. The HNMPC ligand acts as a monoanionic tridentate ONO donor in all complexes, and the coordinating sites are C=Opyridone, C=N, and the phenolate anion. All metal complexes exhibit octahedral configurations, and the results showed that the metal ion:ligand ratio was 1:2. The molecular structural parameters of the ligand and its metal complexes were determined based on the DFT level implemented in the Gaussian 09 program B3LYP/GENECP method at the 6‐311G(d,p) basis set for C, H, N, and O atoms and the SDD (Stuttgart/Dresden) basis set for the metal atoms. The theoretical data were correlated with the experimental results. Gram‐positive bacteria, Gram‐negative bacteria, yeast, and fungi were used to test the current compounds' antimicrobial activity. Investigating the antitumor activity of the ligand and its complexes against the HepG2 cell lines showed encouraging IC50 values that were on par with those of cisplatin. In order to determine the affinity and binding pattern for the synthesized compounds toward the VEGFR‐2 active site, molecular docking studies were conducted, and the results were correlated with antitumor data. Based on the obtained results, future work aimed to synthesize a new category of Schiff bases and their metal complexes derived from the current aminopyridine derivative with diverse aldehydes and ketones.
- 16 September 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 38 (12)
Novel Cu(II) and Zn(II) Nanocomplexes Based on 5,6‐Diphenyl‐1,2,4‐Triazine: Preparation, Spectroscopic, TD‐DFT Calculations, Molecular Docking and Solvatochromic Studies
The reaction between 2‐hydroxy‐1‐naphthaldehyde and 3‐hydrazino‐5,6‐diphenyl‐1,2,4‐triazine produced a novel hydrazone ligand (DTHMN), which reacted with Cu(II) and Zn(II) metal ion in molar ratio 1:1, giving octahedral Cu(II)‐DTHMN and tetrahedral Zn(II)‐DTHMN nanosized complexes. The structural geometries have been elucidated on the basis of elemental analysis, nuclear magnetic resonance, infrared, electronic, and electron spin resonance spectra, and magnetic and molar conductance measurements as well as x‐ray diffraction and thermal analysis. TEM analysis showed that Zn(II)‐DTHMN complex has nano‐rode morphology shape. On the other hand, Cu(II)‐DTHMN has sphere shape within nanodomain. The DTHMN ligand exhibits ONN chelating sites through N‐triazine ring, azomethine nitrogen, and deprotonated OH group, forming the mononuclear metal complexes. The synthesized compounds showed a distinct solvatochromic behavior in different polar solvents. A bathochromic alteration is observed when moving from less to high polar solvents, indicating strong solute–solvent interactions accompanied by intramolecular charge transfer (ICT). The ground and excited state dipole moments of these compounds were determined experimentally by solvatochromic shift method using Bilot–Kawski, Lippert–Mataga, Bakhshiev, and Kawski–Chamma–Viallet functions and a microscopic Reichardt's solvent polarity parameter (ETN). The dipole moment is increased significantly upon excitation referring to stabilizing the excited species includes n–π* transition by polarity of solvent. The experimental results are generally consistent with those values obtained by B3LYP/GENECP method at 6‐311G(d,p) basis set for C, H, N, and O atoms and SDD (Stuttgart/Dresden) basis set for the metal atoms. The compounds were tested for antimicrobial efficiency against Gram‐positive bacteria, Gram‐negative bacteria, and fungus strain. Finally, molecular docking was used to study the interactions between donors (the current compounds) and receptors FabH–CoA complex (PDB code: 1HNJ).
- 16 September 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 38 (12)
Novel Cu(II) and Zn(II) Nanocomplexes Based on 5,6‐Diphenyl‐1,2,4‐Triazine: Preparation, Spectroscopic, TD‐DFT Calculations, Molecular Docking and Solvatochromic Studies
The reaction between 2‐hydroxy‐1‐naphthaldehyde and 3‐hydrazino‐5,6‐diphenyl‐1,2,4‐triazine produced a novel hydrazone ligand (DTHMN), which reacted with Cu(II) and Zn(II) metal ion in molar ratio 1:1, giving octahedral Cu(II)‐DTHMN and tetrahedral Zn(II)‐DTHMN nanosized complexes. The structural geometries have been elucidated on the basis of elemental analysis, nuclear magnetic resonance, infrared, electronic, and electron spin resonance spectra, and magnetic and molar conductance measurements as well as x‐ray diffraction and thermal analysis. TEM analysis showed that Zn(II)‐DTHMN complex has nano‐rode morphology shape. On the other hand, Cu(II)‐DTHMN has sphere shape within nanodomain. The DTHMN ligand exhibits ONN chelating sites through N‐triazine ring, azomethine nitrogen, and deprotonated OH group, forming the mononuclear metal complexes. The synthesized compounds showed a distinct solvatochromic behavior in different polar solvents. A bathochromic alteration is observed when moving from less to high polar solvents, indicating strong solute–solvent interactions accompanied by intramolecular charge transfer (ICT). The ground and excited state dipole moments of these compounds were determined experimentally by solvatochromic shift method using Bilot–Kawski, Lippert–Mataga, Bakhshiev, and Kawski–Chamma–Viallet functions and a microscopic Reichardt's solvent polarity parameter (ETN). The dipole moment is increased significantly upon excitation referring to stabilizing the excited species includes n–π* transition by polarity of solvent. The experimental results are generally consistent with those values obtained by B3LYP/GENECP method at 6‐311G(d,p) basis set for C, H, N, and O atoms and SDD (Stuttgart/Dresden) basis set for the metal atoms. The compounds were tested for antimicrobial efficiency against Gram‐positive bacteria, Gram‐negative bacteria, and fungus strain. Finally, molecular docking was used to study the interactions between donors (the current compounds) and receptors FabH–CoA complex (PDB code: 1HNJ).
- 25 July 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 38 (9)
Preparation, physicochemical, anticancer, and theoretical studies of mono‐ and bi‐nuclear Ni(II), Co(II), and Cd(II) complexes containing chromone moiety
Reactions of a chromone‐based hydrazone (SalHFC; HL) with Ni(II), Co(II), and Cd(II) ions yielded new solid chelates with the general formula [M(L)X].nZ, M = Ni(II), Co(II) and Cd(II), X = NO3− or OAc−, n = 0.5–2, Z = H2O or EtOH for complexes 1, 3, 4, 6, 7, 8 and [M2(L)(OAc)3X].0.5EtOH.nH2O, M = Ni(II) and Co(II), X = H2O or EtOH, n = 1 or zero for complexes 2 and 5. The synthesized chelates have been successfully characterized by means of different analytical and spectroscopic tools. SalHFC performs as a monoanionic tridentate in all chelates except chelate 2 and 5 (monoanionic tetradentate). Molar conductivity measurements demonstrated a non‐electrolytic manner of all chelates. Nickel(II) and cobalt(II)‐SalHFC chelates displayed tetrahedral geometries whereas cadmium(II) chelates (7 and 8) were octahedral. TG was employed to inspect the thermal degradation patterns of SalHFC‐complexes, and the Coats‐Redfern equations were employed to estimate the kinetic parameters of the thermal degradation steps. Density functional theory (DFT) level implementation in the Gaussian 09 program at B3LYP/6‐311G(d,p) level was efficaciously used to predict the molecular structural properties of SalHFC and its chelates and the theoretical data and experimental findings were then integrated. SalHFC and its chelates displayed anticancer action against the HepG2 cell line and the results were verified by molecular docking studies.
- 25 July 2024
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 38 (9)
Preparation, physicochemical, anticancer, and theoretical studies of mono‐ and bi‐nuclear Ni(II), Co(II), and Cd(II) complexes containing chromone moiety
Reactions of a chromone‐based hydrazone (SalHFC; HL) with Ni(II), Co(II), and Cd(II) ions yielded new solid chelates with the general formula [M(L)X].nZ, M = Ni(II), Co(II) and Cd(II), X = NO3− or OAc−, n = 0.5–2, Z = H2O or EtOH for complexes 1, 3, 4, 6, 7, 8 and [M2(L)(OAc)3X].0.5EtOH.nH2O, M = Ni(II) and Co(II), X = H2O or EtOH, n = 1 or zero for complexes 2 and 5. The synthesized chelates have been successfully characterized by means of different analytical and spectroscopic tools. SalHFC performs as a monoanionic tridentate in all chelates except chelate 2 and 5 (monoanionic tetradentate). Molar conductivity measurements demonstrated a non‐electrolytic manner of all chelates. Nickel(II) and cobalt(II)‐SalHFC chelates displayed tetrahedral geometries whereas cadmium(II) chelates (7 and 8) were octahedral. TG was employed to inspect the thermal degradation patterns of SalHFC‐complexes, and the Coats‐Redfern equations were employed to estimate the kinetic parameters of the thermal degradation steps. Density functional theory (DFT) level implementation in the Gaussian 09 program at B3LYP/6‐311G(d,p) level was efficaciously used to predict the molecular structural properties of SalHFC and its chelates and the theoretical data and experimental findings were then integrated. SalHFC and its chelates displayed anticancer action against the HepG2 cell line and the results were verified by molecular docking studies.